loadpatents
name:-0.016875982284546
name:-0.011394023895264
name:-0.0056390762329102
SEENISAMY; Jeyaprakashnarayanan Patent Filings

SEENISAMY; Jeyaprakashnarayanan

Patent Applications and Registrations

Patent applications and USPTO patent grants for SEENISAMY; Jeyaprakashnarayanan.The latest application filed is for "indene derivatives useful in treating pain and inflammation".

Company Profile
6.10.16
  • SEENISAMY; Jeyaprakashnarayanan - Vancouver CA
  • Seenisamy; Jeyaprakashnarayanan - Bangalore IN
  • Seenisamy; Jeyaprakashnarayanan - Karnataka IN
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Indene Derivatives Useful In Treating Pain And Inflammation
App 20220306645 - HARWIG; Curtis ;   et al.
2022-09-29
Indene derivatives useful in treating pain and inflammation
Grant 11,420,962 - Harwig , et al. August 23, 2
2022-08-23
Process for manufacturing (S)-3-hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide
App 20220251072 - Heinrich; Timo ;   et al.
2022-08-11
Indene derivatives useful in treating pain and inflammation
Grant 11,352,367 - Harwig , et al. June 7, 2
2022-06-07
Heteroaryl compounds as BTK inhibitors and uses thereof
Grant 11,098,041 - Gaillard , et al. August 24, 2
2021-08-24
Indene Derivatives Useful In Treating Pain And Inflammation
App 20210155615 - HARWIG; Curtis ;   et al.
2021-05-27
Indene Derivatives Useful In Treating Pain And Inflammation
App 20210032264 - HARWIG; Curtis ;   et al.
2021-02-04
Hexadecahydro-1h-cyclopenta[a]phenanthrene Derivatives Useful In Treating Pain And Inflammation
App 20210024571 - HARWIG; Curtis ;   et al.
2021-01-28
Tyrosine Kinase Non-Receptor 1 (TNK1) Inhibitors and Uses Thereof
App 20210000825 - Siddiqui-Jain; Adam ;   et al.
2021-01-07
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof
App 20190233417 - Gaillard; Pascale ;   et al.
2019-08-01
Heteroaryl compounds as BTK inhibitors and uses thereof
Grant 10,253,023 - Gaillard , et al.
2019-04-09
Cyclic amides as MetAP-2 inhibitors
Grant 10,093,623 - Heinrich , et al. October 9, 2
2018-10-09
Synthesis of a substituted indene derivative
Grant 10,053,415 - Harwig , et al. August 21, 2
2018-08-21
Synthesis Of A Substituted Indene Derivative
App 20180086691 - Harwig; Curtis ;   et al.
2018-03-29
Synthesis Of A Substituted Indene Derivative
App 20170204048 - Harwig; Curtis ;   et al.
2017-07-20
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
Grant 9,688,702 - Swinnen , et al. June 27, 2
2017-06-27
Imidazopyrimidine derivatives
Grant 9,617,266 - Hoelzemann , et al. April 11, 2
2017-04-11
Alpha hydroxy amides
Grant 9,585,891 - Muzerelle , et al. March 7, 2
2017-03-07
Novel Quinoline Derivatives And Their Use In Neurodegenerative Diseases
App 20160296509 - KARRA; Srinivasa R. ;   et al.
2016-10-13
Quinoline derivatives and their use in neurodegenerative diseases
Grant 9,399,623 - Karra , et al. July 26, 2
2016-07-26
Heteroaryl Compounds As Btk Inhibitors And Uses Thereof
App 20160096834 - GAILLARD; Pascale ;   et al.
2016-04-07
Imidazopyrimidine Derivatives
App 20160002242 - HOELZEMANN; Guenter ;   et al.
2016-01-07
Novel Quinoline Derivatives And Their Use In Neurodegenerative Diseases
App 20150353497 - KARRA; Srinivasa R. ;   et al.
2015-12-10
Alpha Hydroxy Amides
App 20150250792 - Muzerelle; Mathilde ;   et al.
2015-09-10
Cyclic Amides As Metap-2 Inhibitors
App 20150031670 - Heinrich; Timo ;   et al.
2015-01-29
Alpha-amino boronic acid derivatives, selective immunoproteasome inhibitors
App 20140364396 - Swinnen; Dominique ;   et al.
2014-12-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed